Adar1 Capital Management, LLC Arbutus Biopharma Corp Transaction History
Adar1 Capital Management, LLC
- $441 Billion
- Q1 2024
A detailed history of Adar1 Capital Management, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 2,074,183 shares of ABUS stock, worth $6.41 Million. This represents 1.21% of its overall portfolio holdings.
Number of Shares
2,074,183
Previous 3,468,824
40.21%
Holding current value
$6.41 Million
Previous $8.67 Billion
38.29%
% of portfolio
1.21%
Previous 3.1%
Shares
2 transactions
Others Institutions Holding ABUS
# of Institutions
130Shares Held
82.2MCall Options Held
4.82MPut Options Held
546K-
Whitefort Capital Management, LP New York, NY12.9MShares$39.7 Million24.48% of portfolio
-
Black Rock Inc. New York, NY10.4MShares$32.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY8.83MShares$27.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY7.84MShares$24.2 Million10.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.99MShares$18.5 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $463M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...